Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1177/20552173211017159 http://scihub22266oqcxt.onion/10.1177/20552173211017159 34104472!8172949!34104472     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Mult+Scler+J+Exp+Transl+Clin 2021 ; 7 (2): 20552173211017159 Nephropedia Template TP {{tp|p=34104472|t=2021. COVID-19 vaccination willingness among people with multiple sclerosis |pdf=|usr=}}{{34104472}} gab.com Text COVID-19 vaccination willingness among people with multiple sclerosis JO: Mult Scler J Exp Transl Clin http://www.kidney.de/pget.php?&tw=1&pmid=34104472 #FOAvip BACKGROUND: Hesitancy to receive COVID-19 vaccination is a major public health concern. COVID-19 vaccine willingness and the factors contributing to willingness in adults with multiple sclerosis (MS) is unknown. We administered an online survey from 1 December 2020 to 7 January 2021 to adults with MS to estimate COVID-19 vaccine willingness among adults with MS. Bivariate analysis with chi-square testing compared categorical variables associated with vaccine willingness. RESULTS: Of 401 respondents, 70.1% were willing to receive an authorized COVID-19 vaccination if it was available to them, 22.7% were unsure, and 7.2% were unwilling. The most frequent concern for those unsure was vaccine safety. Vaccine willingness was associated with increased perceived personal risk of COVID-19 (chi(2) = 45.4; p < 0.0001), prior influenza vaccine acceptance (chi(2) = 97.6; p < 0.0001), higher educational level (chi(2) = 50.2; p < 0.0001), and if respondents discussed or planned to discuss the COVID-19 vaccine with their neurologists (chi(2) = 64.3; p < 0.0001). CONCLUSION: While COVID-19 vaccination willingness is high among people with MS, nearly 30% were either unwilling or unsure about being vaccinated. Neurologists should be aware of patient-centered factors associated with COVID-19 vaccine willingness and address COVID-19 vaccine safety concerns in discussions with their vaccine-unsure MS patients. Twit Text FOAVip COVID-19 vaccination willingness among people with multiple sclerosis ????Mult Scler J Exp Transl Clin http://www.kidney.de/pget.php?&tw=1&pmid=34104472 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34104472 #FOAvip English Wikipedia <ref>{{Cite pmid|34104472}}</ref> COVID-19 vaccination willingness among people with multiple sclerosis #MMPMID34104472 Xiang XM; Hollen C; Yang Q; Brumbach BH; Spain RI; Wooliscroft L Mult Scler J Exp Transl Clin 2021[Apr]; 7 (2): 20552173211017159 PMID34104472show ga BACKGROUND: Hesitancy to receive COVID-19 vaccination is a major public health concern. COVID-19 vaccine willingness and the factors contributing to willingness in adults with multiple sclerosis (MS) is unknown. We administered an online survey from 1 December 2020 to 7 January 2021 to adults with MS to estimate COVID-19 vaccine willingness among adults with MS. Bivariate analysis with chi-square testing compared categorical variables associated with vaccine willingness. RESULTS: Of 401 respondents, 70.1% were willing to receive an authorized COVID-19 vaccination if it was available to them, 22.7% were unsure, and 7.2% were unwilling. The most frequent concern for those unsure was vaccine safety. Vaccine willingness was associated with increased perceived personal risk of COVID-19 (chi(2) = 45.4; p < 0.0001), prior influenza vaccine acceptance (chi(2) = 97.6; p < 0.0001), higher educational level (chi(2) = 50.2; p < 0.0001), and if respondents discussed or planned to discuss the COVID-19 vaccine with their neurologists (chi(2) = 64.3; p < 0.0001). CONCLUSION: While COVID-19 vaccination willingness is high among people with MS, nearly 30% were either unwilling or unsure about being vaccinated. Neurologists should be aware of patient-centered factors associated with COVID-19 vaccine willingness and address COVID-19 vaccine safety concerns in discussions with their vaccine-unsure MS patients. äCOVID-19 vaccination willingness among people with multiple sclerosis (epmc).pdf DeepDyve Pubget Overpricing